Richard Massey
Director, Medical Writing
Richard leads Clarivate’s Value Communication Centre of Excellence and provides strategic guidance for the team of medical writers and creative designers. Having come from a scientific marketing background, Richard brings an astute commercial perspective to the team. Collaborating with clients in the pharmaceutical and medical device industries, Richard has successfully delivered payer value propositions, objection handlers, evidence dossiers, HTA submissions, publications, and training workshops for Top 10 Pharma brands across a comprehensive range of treatment and domain areas. Richard has considerable experience message testing in major markets. He has hosted workshops on value proposition development, objection handling, payer archetypes and HTA trends, and has developed and presented webinars on a variety of market access topics.
Richard has over 10 years of experience in scientific communication roles. Prior to joining Clarivate, Richard was content lead at a Cambridge-based life science marketing agency, creating collateral for global life science brands. His work has featured in leading trade media publications and has been published by Nature, Scientific American and Chemistry World. Richard has a PhD in Organic Chemistry from Durham University.
Latest news
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle London, U.K. — August 6, 2026— Clarivate…
Clarivate Companies to Watch Report Spotlights Seven Innovators Shaping the Next Generation of Obesity Therapies
New report examines novel mechanisms and emerging approaches advancing obesity treatment beyond today’s GLP-1 therapies London, U.K., August 5, 2026 — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative…
Clarivate Appoints Michael Easton as Chief Financial Officer
Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate” or the “Company”), a leading global provider of transformative intelligence, today…
